Denali Therapeutics Inc.

132 articles about Denali Therapeutics Inc.

• 

  Run by Former Genentech Employees, Bay Area's Denali Seeks $100M IPO

  11/14/2017

  Denali plans to make a $100M IPO under the symbol DNLI.

• What You Need to Know About Denali

  1/12/2017

• 

  The Next Generation: Top 20 Life Science Startups to Watch in 2017

  1/9/2017

  BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.

• Led by Former Genentech Execs, Denali Banks $130 Million, Initiates Trial and Announces a Handful of Partnerships

  8/26/2016

• f-Star Announces Collaborative Agreement With Denali For The Development Of A Multispecific Antibody Platform To Deliver Therapeutics Across The Blood-Brain Barrier

  8/25/2016

• Nine Bay Area Biotechs Vie to be the “Next Genentech”

  5/26/2016

• Inside the $50 Billion Biotech Sugar Daddy that Invested in Startups Like Denali, Juno

  3/7/2016

• Denali, Helmed by Former Genentech Execs, Takes Space in South San Francisco Site

  1/20/2016

• Denali Appoints Steve E. Krognes As Chief Financial Officer

  9/8/2015

• Denali Appoints Carole Ho, M.D., As Chief Medical Officer And Head Of Development

  7/22/2015

• Pfizer Board Member Jumps Ship to $217 Million Startup Denali

  5/22/2015

• Why Denali Raised A $217 Million Financing Round: Not Just "Because It Could"

  5/21/2015